Clinical Trials/ChiCTR1800018161

ChiCTR1800018161Active, not recruiting卫生服务研究

提高社区眼病筛查率方法的整群随机对照研究

浙江省科技惠民计划项目1 site in 1 country12,094 target enrollmentStarted: September 16, 2018Last updated: September 2, 2018

Trial Snapshot

Phase: 卫生服务研究
Status: Active, not recruiting
Sponsor
Enrollment: 12,094
Locations: 1
Primary Endpoint: 社区眼病筛查参与率

Study Overview Study Design Eligibility Criteria Arms & Interventions Outcomes Investigators Sites Records & Identifiers Similar Trials

Study Overview

Brief Summary

检验并比较提高社区筛查诊所居民眼病筛查率一系列干预措施的可行性和临床有效性。

Study Design

Study Type: 卫生服务研究
Primary Purpose: 整群随机分组
Masking: None

Eligibility Criteria

Ages: 3 to 80 (—)
Sex: All

Inclusion Criteria

•（1）具有乐清眼病筛查项目覆盖区域（柳市镇、乐成街道、城东街道、城南街道、盐盆街道）的户籍；
•（2）年龄介于 3-80 岁；
•（3）乐清眼病筛查项目视力筛查参与者；
•（4）单眼生活视力＜0.5 或双眼视力相差 2 行；
•（5）未曾来社区眼病诊所进行眼病筛查。

Exclusion Criteria

•（1）患有严重系统性疾病或精神疾患不能配合眼科相关检查者；
•（2）拒绝签署知情同意书者。

Arms & Interventions

试验组 1

村干部通知各村低视力可疑者，并预约时间由项目组提供车辆接送该村低视力可疑者前去眼病筛查诊所进行眼病筛查

试验组 2

干预措施为村干部通知各村低视力可疑者，项目组为前来眼病筛查诊所进行眼病筛查者提供 10 元交通补贴

平行对照组

村干部通知

Outcomes

Primary Outcomes

社区眼病筛查参与率

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor

浙江省科技惠民计划项目

Study Sites (1)

Loading locations...

Similar Trials

A Randomised Control Study To Compare The Efficacy Of Intravitreal Faricimab6.0 mg Versus Aflibercept 2.0 mg In Management of Treatment Naive Diabetic Macular Edema In Indian Population

CTRI/2024/09/073550Army Hospital Research And Referral72

School screening program (SSP), Sundargarh

CTRI/2025/08/092313Vision Aid50,000

Not yet recruiting

Eye Stinging Potential of Fame labs Soothe Stick

CTRI/2025/10/096414Fame Labs32

Not yet recruiting

Eye Stinging Potential of Purite Baby 3 in 1 TF010625

CTRI/2025/08/093833Marico South East Asia Corporation32

Not yet recruiting

Eye Stinging Potential of Purite Baby 3 in 1 Hair, Face wash Anti-Bacterial

CTRI/2025/08/093120Marico South East Asia Corporation32